Patents by Inventor Gerard Sutton

Gerard Sutton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COLLAGEN IV BIOINKS
    Publication number: 20240033400
    Abstract: The present invention relates to compositions suitable for the delivery of agents to biological targets such as tissues and cells and/or capable of promoting the growth and/or proliferation of cells, and methods for the production thereof. Specifically, a printable collagen bioink comprising type IV collagen is used to produce crosslinked collagen gels comprising mammalian cells, such as endothelial or epithelial cells, for corneal regeneration.
    Type: Application
    Filed: March 18, 2022
    Publication date: February 1, 2024
    Inventors: Jingjing YOU, Gerard SUTTON, Morgan OVERMASS, Frank LOVICU, Gordon WALLACE
  • Collagen gel formulations
    Publication number: 20230001047
    Abstract: The present inventors have developed printable collagen bioinks using unmodified type I collagen with mechanical and structural properties that facilitate application to tissue in a structured form. In particular, the compositions of the present invention may be used to apply collagen gels to tissue (e.g. eye) using two- or three-dimensional (extrusion) bioprinting techniques.
    Type: Application
    Filed: November 18, 2020
    Publication date: January 5, 2023
    Inventors: Gerard SUTTON, Yihui SONG, Jingjing YOU
  • PLATELET LYSATE COMPOSITIONS AND USES THEREOF
    Publication number: 20210290683
    Abstract: The present invention relates to compositions, kits, and methods for providing mechanical support and/or agents to biological targets. Specifically, the compositions comprise platelet lysate, fibrinogen and thrombin. The compositions can be used for the treatment of wounds/injuries (e.g. corneal), and for other applications including tissue culture.
    Type: Application
    Filed: August 7, 2019
    Publication date: September 23, 2021
    Inventors: Gerard Sutton, JingJing You, Hannah Frazer
  • DIAGNOSTIC AND THERAPEUTIC METHODS FOR CORNEAL ECTASIA FOLLOWING REFRACTIVE SURGERY, KERATOCONUS OR PELLUCID DEGENERATION
    Publication number: 20130058954
    Abstract: The present invention relates to methods of diagnosis and treatment of corneal ectasia following refractive surgery, keratoconus or pellucid marginal degeneration in a subject by determining or modulating the level of expression of molecules associated with the Wnt signalling pathway. Marker molecules of the present invention include SFRP1, PITX2, LEF1, WNT16 and WNT5A.
    Type: Application
    Filed: December 2, 2010
    Publication date: March 7, 2013
    Applicant: THE UNIVERSITY OF SYDNEY
    Inventors: Gerard Sutton, John McAvoy, Michele Madigan